Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: It is known that adverse reactions following SARS-CoV-2 vaccinations show a positive correlation with the subsequent antibody titer. However, it is not clear how the adverse reactions following the booster vaccination are related to the antibody levels that can be measured after a 3rd dose. The primary goal of this study was to investigate whether the adverse reactions following the booster vaccination show a correlation with subsequent antibody levels.

Methods: Adverse reactions occurring within 7 days after the 3rd vaccination were recorded and the anti-SARS-CoV-2 spike protein immunoglobulin (Ig) level in the venous blood was measured on post-vaccination 14th, 60th and 120th days.

Results: A total of 218 volunteers were included in the study.

Main Findings: (i) The adverse reactions that appeared after the booster dose did not show a positive correlation with the subsequent antibody level, except a correlation in the case of fever; (ii) there were more symptomatic patients in the group receiving heterologous booster vaccine, (iii) fever after the 2nd dose was independently associated with a reduction in the likelihood of COVID-19 positivity after the booster dose.

Conclusion: No adverse reactions, but fever showed a correlation with the antibody level after the booster SARS-CoV-2 vaccine.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864400PMC
http://dx.doi.org/10.3390/vaccines11010182DOI Listing

Publication Analysis

Top Keywords

adverse reactions
28
reactions booster
12
correlation subsequent
12
subsequent antibody
12
booster sars-cov-2
8
positive correlation
8
booster vaccination
8
antibody level
8
adverse
7
booster
7

Similar Publications

Adhesive materials are widely used in microvascular decompression for treating neurovascular compression syndromes. They play an important role in the critical step of vessel fixation. Recently, completely autologous fibrin glue produced solely from a patient's own plasma was developed.

View Article and Find Full Text PDF

[Effect of Kamishoyosan on Primary Dysmenorrhea Pain].

Yakugaku Zasshi

September 2025

Kampo Research Laboratories, Pharmaceutical Company, Kracie, Ltd.

Dysmenorrhea refers to pathological symptoms that occur in association with menstruation during the menstrual period. Treatment options for dysmenorrhea include nonsteroidal anti-inflammatory drugs (NSAIDs) and low-dose estrogen-progestin combination pills. However, some patients do not respond to these treatments, and long-term use can lead to adverse reactions, raising additional problems.

View Article and Find Full Text PDF

Modelling allopurinol-induced severe adverse cutaneous reactions.

Lancet Rheumatol

September 2025

University of Otago Christchurch, Christchurch, New Zealand; Christchurch Hospital, Health New Zealand Waitaha, Christchurch, New Zealand.

View Article and Find Full Text PDF

Background: Allopurinol, the most prescribed urate-lowering drug, is a known cause of severe cutaneous adverse reactions. We aimed to develop and validate a model to assess the risk of allopurinol-induced severe cutaneous adverse reactions in adults newly prescribed allopurinol.

Methods: In this retrospective new-user cohort study, we developed and validated a prognostic model using primary care, hospitalisation, and mortality data extracted from the UK Clinical Practice Research Datalink (CPRD) primary care database, for the period Jan 1, 2001, to March 29, 2021.

View Article and Find Full Text PDF

Aim: This study evaluates the efficacy and safety of scalp acupuncture in treating tic disorders.

Methods: We conducted a meta-analysis using data from 19 randomized controlled trials (RCTs) involving 1463 patients, sourced from various databases up to May 16, 2023. Stata15.

View Article and Find Full Text PDF